NASD · Healthcare · Medical Instruments & Supplies · USA
Cooper Companies Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Instruments & Supplies industry.
Cooper Companies is a medical device company operating through two segments: CooperVision and CooperSurgical. CooperVision manufactures contact lenses for vision correction, including products for astigmatism, presbyopia, and myopia management, serving customers across multiple countries. CooperSurgical provides medical devices and services for fertility and women's health, serving hospitals, surgery centers, medical offices, and fertility clinics worldwide.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Cooper Companies Inc stock.
Fairly valued: intrinsic value $61.35 per share, market price $59.55, margin of safety 2.9% (as of 2026-10-30).
Discounting its cash flows at 8.8% (average of 3 methods) values the shares at $61.35; the price of $59.55 is 3% below that value, and 77% of that value comes from beyond year five.
Leak Score: 59/100 on 12 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 51 Medical Instruments & Supplies stocks
COO is fairly valued (as of the 2026-10-30 close). Discounting its cash flows at 8.8% (average of 3 methods) values the shares at $61.35; the price of $59.55 is 3% below that value, and 77% of that value comes from beyond year five.
$61.35 per share (as of the 2026-10-30 close), against a market price of $59.55. That is a margin of safety of 2.9%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
59 out of 100, which we rate "Weak Signal", on 12 of 12 value investing signals.